128 related articles for article (PubMed ID: 6195095)
1. Immunogenicity of transfer RNA isolated from a two-heptose rough mutant of Salmonella typhimurium LT2 in mouse typhoid infection.
Kita E; Kashiba S
Immunology; 1983 Nov; 50(3):369-76. PubMed ID: 6195095
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. I. Requirement of the antibody to non-O antigen for protection in mice that are not protected by the RNA-rich vaccine.
Kita E; Nishi K; Emoto M; Katsui N; Yasui K; Yasui K; Kashiba S
Immunology; 1987 Aug; 61(4):535-41. PubMed ID: 2450832
[TBL] [Abstract][Full Text] [Related]
3. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.
Kita E; Emoto M; Katsui N; Nishi K; Yasui K; Yasui K; Kashiba S
Immunology; 1987 Oct; 62(2):235-40. PubMed ID: 2445665
[TBL] [Abstract][Full Text] [Related]
4. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium III. Analysis of resistance induced by dialyzable factors.
Kita E; Yasui K; Yasui K; Matsuda Y; Matsuda K; Kashiba S
Microbiol Immunol; 1984; 28(7):807-20. PubMed ID: 6436650
[TBL] [Abstract][Full Text] [Related]
5. Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.
Kita E; Emoto M; Yasui K; Yasui K; Katsui N; Nishi K; Kashiba S
Immunology; 1986 Mar; 57(3):431-5. PubMed ID: 3514442
[TBL] [Abstract][Full Text] [Related]
6. Poor survival but high immunogenicity of IL-2-expressing Salmonella typhimurium in inherently resistant mice.
al-Ramadi BK; Bashir G; Rizvi TA; Fernandez-Cabezudo MJ
Microbes Infect; 2004 Apr; 6(4):350-9. PubMed ID: 15050962
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of the protective immunity against murine typhoid: persistence of Salmonella L forms in the liver after immunization with live-cell vaccines.
Kita E; Nishikawa F; Kamikaidou N; Oku D; Yasui K; Kashiba S
FEMS Microbiol Immunol; 1992 Oct; 5(4):191-9. PubMed ID: 1419117
[TBL] [Abstract][Full Text] [Related]
8. Protective immunities induced by porins from mutant strains of Salmonella typhimurium.
Matsui K; Arai T
Microbiol Immunol; 1990; 34(11):917-27. PubMed ID: 1965322
[TBL] [Abstract][Full Text] [Related]
9. Effect of slime extract from Pseudomonas aeruginosa on cell mediated immunity induced in mice by Salmonella typhimurium.
Lagowska-Złotorzycka M; Czarny A; Mulczyk M
Arch Immunol Ther Exp (Warsz); 1987; 35(3):277-81. PubMed ID: 3128243
[TBL] [Abstract][Full Text] [Related]
10. Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor.
Kita E; Matsuda Y; Matsuda K; Kashiba S
Cell Immunol; 1984 Sep; 87(2):528-37. PubMed ID: 6380767
[TBL] [Abstract][Full Text] [Related]
11. Passive secretory immunity against Salmonella typhimurium demonstrated with foster mouse pups.
Shope SR; Schiemann DA
J Med Microbiol; 1991 Jul; 35(1):53-9. PubMed ID: 2072379
[TBL] [Abstract][Full Text] [Related]
12. [Active immunization to experimental salmonellosis in mice protective properties of Salmonella R mutants against infection with different pathogenic Salmonella species (author's transl)].
Schlecht S
Zentralbl Bakteriol A; 1981 Aug; 249(3):362-72. PubMed ID: 7023133
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.
Kita E; Matsuura H; Masuda S; Tomihata S; Kashiba S
Microbiol Immunol; 1983; 27(1):7-24. PubMed ID: 6346023
[TBL] [Abstract][Full Text] [Related]
14. Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium.
Singh SP; Williams YU; Benjamin WH; Klebba PE; Boyd D
Microb Pathog; 1996 Oct; 21(4):249-63. PubMed ID: 8905614
[TBL] [Abstract][Full Text] [Related]
15. Specificity of protective immunity induced by porin from Salmonella typhimurium.
Matsui K; Arai T
Microbiologica; 1991 Apr; 14(2):103-12. PubMed ID: 1649959
[TBL] [Abstract][Full Text] [Related]
16. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.
Lin JH; Berry LJ
J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689
[No Abstract] [Full Text] [Related]
17. [Oral immunization with non-viable micro-organisms or their antigens. 15. Immunogenicity from fractions of S. typhi murium bacteria in the mouse protection test].
Birnschein E; Herrmann R; Kolb HJ; Brehmer W; Raettig H
Zentralbl Bakteriol Orig A; 1972 Dec; 222(3):314-25. PubMed ID: 4145495
[No Abstract] [Full Text] [Related]
18. Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
Venneman MR; Berry LJ
Infect Immun; 1971 Oct; 4(4):374-80. PubMed ID: 4949497
[TBL] [Abstract][Full Text] [Related]
19. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
Nickol AD; Bonventre PF
J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
[TBL] [Abstract][Full Text] [Related]
20. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
